NOVEL INHIBITORS FOR MULTIDRUG-RESISTANCE - 1,3,5-TRIAZACYCLOHEPTANES
Citation
H. Sawanishi et al., NOVEL INHIBITORS FOR MULTIDRUG-RESISTANCE - 1,3,5-TRIAZACYCLOHEPTANES, Journal of medicinal chemistry, 38(26), 1995, pp. 5066-5070
Categorie Soggetti
Chemistry Medicinal
SICI code
0022-2623(1995)38:26<5066:NIFM-1>2.0.ZU;2-5
Abstract
1,3,5-Triazacycloheptanes were synthesized and examined for reversal o
f the multidrug resistance dependent on P-glycoprotein. Most of these
compounds increased the intracellular uptake of vinblastine in multidr
ug-resistant mouse leukemia P388/ADR cells without influence upon the
vinblastine accumulation in P388/S cells. The efficacy of 1,5-dibenzyl
-1,3,5-triazacycloheptanes in increasing the vinblastine accumulation
was in the order of 2,4-dithioxo (5) > 2-oxo-4-thioxo (4) approximate
to 4-(methylthio)-2-oxo (6) > 2,4-dioxo (2). The efficacy was further
increased when the benzyl group was converted to a chlorobenzyl group.
Among these compounds, 6c terahydro-4-(methylthio)-2H-1,3,5-triazepin
-2-one] potentiated the in vitro cell growth-inhibitory effect of vinb
lastine, adriamycin, and mitomycin C on P388/ADR cells and prolonged t
he life span of P388/ADR-bearing mice in combined therapy with vinblas
tine more than vinblastine alone.